Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02860286
Title Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Epizyme, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | FRA

Facility Status City State Zip Country Details
University of California, Los Angeles Los Angeles California 90025 United States Details
City of Hope National Medical Center Los Angeles California 90301 United States Details
University of California San Francisco San Francisco California 94143 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Mayo Clinic - Rochester Rochester Minnesota 55905 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Institut Bergonie Bordeaux Cedex 33076 France Details
CHRU de Lille Lille 59037 France Details
Institut Gustave Roussy Villejuif cedex 94805 France Details
University of Leicester & Leicester University Hospitals Leicester LE1 9HN United Kingdom Details
St. Bartholomew's Hospital London EC1M 6BQ United Kingdom Details
University College Hospital London NW1 2PG United Kingdom Details
Royal Marsden Hospital - Chelsea London SW3 6JJ United Kingdom Details
University Hospital of South Manchester Manchester M23 9LT United Kingdom Details
Royal Marsden Hospital - Surrey Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field